Roles and regulatory mechanisms of miR‑30b in cancer, cardiovascular disease, and metabolic disorders
Q Zhang, S Liu, J Zhang, X Ma… - Experimental and …, 2021 - spandidos-publications.com
MicroRNAs (miRNAs) are non‑coding RNAs 21‑23 nucleotides in length that regulate gene
expression, and thereby modulate signaling pathways and protein synthesis in both …
expression, and thereby modulate signaling pathways and protein synthesis in both …
The synergistic effects of SHR6390 combined with pyrotinib on HER2+/HR+ breast cancer
Y Wang, X Yuan, J Li, Z Liu, X Li, Z Wang… - Frontiers in Cell and …, 2021 - frontiersin.org
HER2+/HR+ breast cancer is a special molecular type of breast cancer. Existing treatment
methods are prone to resistance;“precision treatment” is necessary. Pyrotinib is a pan-her …
methods are prone to resistance;“precision treatment” is necessary. Pyrotinib is a pan-her …
[HTML][HTML] Current insights into the molecular systems pharmacology of lncRNA-miRNA regulatory interactions and implications in cancer translational medicine
S Nair - AIMS Molecular Science, 2016 - aimspress.com
In recent times, the role (s) of microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) in
the pathogenesis of various cancers has received great attention. Indeed, there is also a …
the pathogenesis of various cancers has received great attention. Indeed, there is also a …